Nathan P. Clark

5.1k total citations · 1 hit paper
62 papers, 2.2k citations indexed

About

Nathan P. Clark is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Toxicology. According to data from OpenAlex, Nathan P. Clark has authored 62 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Cardiology and Cardiovascular Medicine, 33 papers in Internal Medicine and 6 papers in Toxicology. Recurrent topics in Nathan P. Clark's work include Atrial Fibrillation Management and Outcomes (43 papers), Venous Thromboembolism Diagnosis and Management (33 papers) and Cardiac Arrhythmias and Treatments (8 papers). Nathan P. Clark is often cited by papers focused on Atrial Fibrillation Management and Outcomes (43 papers), Venous Thromboembolism Diagnosis and Management (33 papers) and Cardiac Arrhythmias and Treatments (8 papers). Nathan P. Clark collaborates with scholars based in United States, Canada and Italy. Nathan P. Clark's co-authors include Daniel M. Witt, David García, Mark Crowther, Thomas Delate, Walter Ageno, Elaine M. Hylek, Francesco Dentali, Scott Kaatz, Jack Ansell and Arthur L. Allen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Annals of Internal Medicine.

In The Last Decade

Nathan P. Clark

58 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy

2018 329 citations Daniel M. Witt, Robby Nieuwlaat et al. Blood Advances profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nathan P. Clark United States	22	1.3k	1.1k	326	305	259	62	2.2k
Steven Deitelzweig United States	24	1.2k 0.9×	1.0k 0.9×	378 1.2×	275 0.9×	166 0.6×	105	2.3k
Geoffrey D. Barnes United States	26	1.9k 1.5×	1.9k 1.7×	451 1.4×	418 1.4×	259 1.0×	234	3.4k
John Fanikos United States	35	1.5k 1.2×	1.6k 1.4×	213 0.7×	758 2.5×	169 0.7×	131	3.4k
William E. Dager United States	31	1.6k 1.2×	1.5k 1.3×	346 1.1×	1.0k 3.3×	228 0.9×	111	3.2k
Paul P. Dobesh United States	23	1.3k 1.0×	981 0.9×	105 0.3×	432 1.4×	115 0.4×	95	2.2k
Sarah A. Spinler United States	28	1.8k 1.4×	805 0.7×	124 0.4×	846 2.8×	84 0.3×	126	3.2k
Daniel M. Witt United States	31	3.1k 2.3×	2.2k 2.0×	109 0.3×	610 2.0×	252 1.0×	153	4.5k
Isabelle Mahé France	27	1.5k 1.1×	1.3k 1.2×	44 0.1×	385 1.3×	31 0.1×	171	2.4k
Carmen Suárez Spain	22	1.0k 0.8×	709 0.6×	43 0.1×	465 1.5×	43 0.2×	87	1.8k
Manuel Anguita Spain	25	1.9k 1.5×	266 0.2×	315 1.0×	462 1.5×	124 0.5×	149	2.6k

Countries citing papers authored by Nathan P. Clark

Since Specialization

Citations

This map shows the geographic impact of Nathan P. Clark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan P. Clark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan P. Clark more than expected).

Fields of papers citing papers by Nathan P. Clark

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathan P. Clark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan P. Clark. The network helps show where Nathan P. Clark may publish in the future.

Co-authorship network of co-authors of Nathan P. Clark

This figure shows the co-authorship network connecting the top 25 collaborators of Nathan P. Clark. A scholar is included among the top collaborators of Nathan P. Clark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathan P. Clark. Nathan P. Clark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Clark, Nathan P., et al.. (2025). Impact of cytochrome P-450 3A4 enzyme/P-glycoprotein inducing antiseizure medications on direct oral anticoagulant therapy. Blood Coagulation & Fibrinolysis. 36(3). 71–77. 1 indexed citations

Clark, Nathan P., Elizabeth R. Kessler, Elaine T. Lam, et al.. (2023). Use of Peripheral Intravenous Access in Patients Undergoing Chemotherapy for Testicular Cancer. JCO Oncology Practice. 20(3). 361–369. 2 indexed citations

Derington, Catherine G., Glenn K. Goodrich, Stanley Xu, et al.. (2023). Association of Direct Oral Anticoagulation Management Strategies With Clinical Outcomes for Adults With Atrial Fibrillation. JAMA Network Open. 6(7). e2321971–e2321971. 4 indexed citations

Clark, Nathan P., et al.. (2023). Safety of direct oral anticoagulant use in patients taking verapamil or diltiazem. Heart Rhythm. 20(12). 1793–1795. 4 indexed citations

Clark, Nathan P., et al.. (2022). Effectiveness and safety of direct oral anticoagulants in patients with venous thromboembolism and creatinine clearance < 30 mL/min. Journal of Thrombosis and Thrombolysis. 55(2). 355–364. 3 indexed citations

Nogueira, Letícia, et al.. (2021). Are outpatient transperineal prostate biopsies without antibiotic prophylaxis equivalent to standard transrectal biopsies for patient safety and cancer detection rates?A retrospective cohort study in 222 patients. Patient Safety in Surgery. 15(1). 28–28. 4 indexed citations

Tafur, Alfonso, Nathan P. Clark, Alex C. Spyropoulos, et al.. (2020). Predictors of Bleeding in the Perioperative Anticoagulant Use for Surgery Evaluation Study. Journal of the American Heart Association. 9(19). e017316–e017316. 31 indexed citations

Barnes, Geoffrey D., Allison Burnett, Arthur L. Allen, et al.. (2020). Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum. Journal of Thrombosis and Thrombolysis. 50(1). 72–81. 318 indexed citations

Delate, Thomas, et al.. (2020). Vitamin K versus warfarin interruption alone in patients without bleeding and an international normalized ratio > 10. Journal of Thrombosis and Haemostasis. 18(5). 1133–1140. 3 indexed citations

10.

Witt, Daniel M., Robby Nieuwlaat, Nathan P. Clark, et al.. (2018). American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy. Blood Advances. 2(22). 3257–3291. 329 indexed citations breakdown →

11.

Delate, Thomas, et al.. (2018). Effect of increased time in the therapeutic range on atrial fibrillation outcomes within a centralized anticoagulation service. Thrombosis Research. 163. 54–59. 13 indexed citations

12.

Clark, Nathan P., James D. Douketis, Vic Hasselblad, et al.. (2017). Predictors of perioperative major bleeding in patients who interrupt warfarin for an elective surgery or procedure: Analysis of the BRIDGE trial. American Heart Journal. 195. 108–114. 23 indexed citations

13.

Witt, Daniel M., Nathan P. Clark, Scott Kaatz, Terri Schnurr, & Jack Ansell. (2016). Guidance for the practical management of warfarin therapy in the treatment of venous thromboembolism. Journal of Thrombosis and Thrombolysis. 41(1). 187–205. 97 indexed citations

14.

Witt, Daniel M., Nathan P. Clark, Allison N. Schroeder, et al.. (2015). Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for intracranial hemorrhage. Thrombosis Research. 136(5). 1040–1044. 30 indexed citations

15.

Clark, Nathan P., Vincent S. Fan, Christopher G. Slatore, et al.. (2014). Dyspnea and Pain Frequently Co-occur among Medicare Managed Care Recipients. Annals of the American Thoracic Society. 11(6). 890–897. 33 indexed citations

16.

Witt, Daniel M., Thomas Delate, Elaine M. Hylek, et al.. (2013). Effect of warfarin on intracranial hemorrhage incidence and fatal outcomes. Thrombosis Research. 132(6). 770–775. 25 indexed citations

17.

Marchesi, Chiara, Matteo Giorgi‐Pierfranceschi, Mark Crowther, et al.. (2011). Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists. Thrombosis and Haemostasis. 106(9). 429–438. 236 indexed citations

18.

Dentali, Francesco, Marco Paolo Donadini, Nathan P. Clark, et al.. (2011). Brand Name versus Generic Warfarin: A Systematic Review of the Literature. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 31(4). 386–393. 46 indexed citations

19.

Witt, Daniel M., Thomas Delate, Mary Beth Dowd, et al.. (2009). Incidence and predictors of bleeding or thrombosis after polypectomy in patients receiving and not receiving anticoagulation therapy. Journal of Thrombosis and Haemostasis. 7(12). 1982–1989. 62 indexed citations

20.

Clark, Nathan P.. (2008). Low-molecular-weight heparin use in the obese, elderly, and in renal insufficiency. Thrombosis Research. 123. S58–S61. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact